Back to Search
Start Over
MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells.
- Source :
-
Life science alliance [Life Sci Alliance] 2019 May 16; Vol. 2 (3). Date of Electronic Publication: 2019 May 16 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- A fast antibody response can be critical to contain rapidly dividing pathogens. This can be achieved by the expansion of antigen-specific B cells in response to T-cell help followed by differentiation into plasmablasts. MicroRNA-155 (miR-155) is required for optimal T-cell-dependent extrafollicular responses via regulation of PU.1, although the cellular processes underlying this defect are largely unknown. Here, we show that miR-155 regulates the early expansion of B-blasts and later on the survival and proliferation of plasmablasts in a B-cell-intrinsic manner, by tracking antigen-specific B cells in vivo since the onset of antigen stimulation. In agreement, comparative analysis of the transcriptome of miR-155-sufficient and miR-155-deficient plasmablasts at the peak of the response showed that the main processes regulated by miR-155 were DNA metabolic process, DNA replication, and cell cycle. Thus, miR-155 controls the extent of the extrafollicular response by regulating the survival and proliferation of B-blasts, plasmablasts and, consequently, antibody production.<br /> (© 2019 Arbore et al.)
- Subjects :
- Animals
Antibody Formation genetics
Antibody Formation immunology
B-Lymphocyte Subsets immunology
Biomarkers
Cell Proliferation
Cell Survival genetics
Immunophenotyping
Lymphocyte Activation genetics
Lymphocyte Activation immunology
Mice
Mice, Knockout
Plasma Cells immunology
B-Lymphocyte Subsets metabolism
MicroRNAs genetics
Plasma Cells metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2575-1077
- Volume :
- 2
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Life science alliance
- Publication Type :
- Academic Journal
- Accession number :
- 31097471
- Full Text :
- https://doi.org/10.26508/lsa.201800244